1.
Königsberg R. Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumab. Radiol Oncol [Internet]. 2014 May 9 [cited 2026 Aug. 13];48(2). Available from: https://www.radioloncol.com/index.php/ro/article/view/1999